Quetiapine Fumarate in pharma franchise in Manipur

Quetiapine Fumarate in PCD pharma franchise in Gangtok

Quetiapine Fumarate in top pharma company in Shimla

Quetiapine Fumarate in pcd pharma supplier in Patna

Quetiapine Fumarate in phama franchise company in India
Quetiapine Fumarate in phama distributor in Jaipur

Home/Products /quetiapine-fumarate-i-point-p-point-25mg-tablets

About the Product

Description


Qtpair 25 Tablet contains Quetiapine Fumarate 25mg, a medication belonging to the class of atypical antipsychotics. It is commonly used in the treatment of schizophrenia, bipolar disorder, and as an adjunct in major depressive disorder. Quetiapine works by modulating the levels of dopamine and serotonin in the brain, helping to manage the symptoms of these mental health conditions.

This medication is effective in addressing positive symptoms of schizophrenia, such as hallucinations and delusions, as well as in stabilizing mood in patients with bipolar disorder. In lower doses, it also provides a sedative effect, making it beneficial for those with insomnia or anxiety.

Qtpair 25 is often started at a low dose and gradually increased, depending on the patient's response and tolerance. It helps manage episodes of mania and depression in bipolar disorder and acts as an adjunct therapy for treatment-resistant depression. Regular monitoring is required to assess side effects and adjust dosage for optimal therapeutic benefits.

While generally well-tolerated, drowsiness, dry mouth, dizziness, and weight gain are common side effects. Some rare but serious side effects include movement disorders and metabolic changes such as elevated blood sugar.

Qtpair 25 should be taken exactly as prescribed, and it is important to follow up with a healthcare provider for ongoing evaluation. Patients should not stop taking it abruptly without consulting their doctor, as sudden withdrawal may lead to a relapse of symptoms or withdrawal symptoms.

Common side effects include drowsiness, dizziness, dry mouth, constipation, and weight gain. Rare side effects include movement disorders, elevated blood sugar, and changes in blood pressure.

Used for the treatment of schizophrenia, bipolar disorder, and as an adjunct in major depressive disorder, aiding in mood stabilization and psychosis management.

Take only under medical supervision. Avoid alcohol while on this medication. Do not stop abruptly without consulting your doctor to prevent withdrawal symptoms. Regular check-ups are necessary to monitor for potential side effects.

Store in a cool, dry place away from moisture, and keep out of reach of children. Do not store in the bathroom.

Get in Touch

Regulatory Compliance & Professional Verification

This catalog is a digital representation of the Cafoli Lifecare portfolio and is intended for use by authorized pharmaceutical distributors and PCD franchise partners.

  • No Consumer Sale: We do not entertain retail inquiries or direct sales to patients.
  • Information Accuracy: While we strive for accuracy, product availability, packaging, and regulatory status may change based on CDSCO guidelines and state-specific drug laws.
  • Medical Advice: Patients are strictly advised not to self-medicate or use this information for treatment. Always consult a qualified medical practitioner.
  • Licensing: All business associations are subject to the submission of valid GST and Drug License (DL) documentation.

Frequently Asked Questions

What are the business opportunities for Quetiapine Fumarate 25 mg Tablets in the PCD pharma franchise market?

Quetiapine Tablets (25 mg) have strong demand in the psychiatry and CNS segment, making them an important low-dose formulation for pharma distributors, wholesalers, and franchise partners. It is widely used for dose initiation, titration, and supportive therapy in psychiatric disorders, ensuring steady prescription-driven demand.

Why should medical distributors include Quetiapine 25 mg Tablets in their product range?

Medical distributors and agencies benefit from the dose-adjustment and supportive therapy demand in psychiatry treatments. Used for starting and adjusting doses in schizophrenia and bipolar disorder Commonly prescribed in adjunct therapy for depression and mood disorders Often used in clinical practice for managing sleep disturbances (physician-guided use) Widely prescribed by psychiatrists and neurophysicians Supports gradual titration to improve patient tolerance and compliance Ensures repeat prescriptions as part of long-term therapy regimens This makes it a support-strength but steady-demand CNS product.

Does Cafoli LifeCare Pvt Ltd offer PCD pharma franchise opportunities for this product?

Yes, Cafoli LifeCare Pvt Ltd offers PCD pharma franchise opportunities for Quetiapine Fumarate 25 mg Tablets with monopoly rights, promotional support, quality manufacturing standards, attractive packaging, and competitive pricing for distributors and wholesalers.

What benefits do wholesalers get by partnering for this product?

Wholesalers and franchise partners benefit from steady psychiatry prescription flow, strong demand in dose-adjustment therapy, repeat monthly sales, and long-term stability in the CNS and mental health segment.

How can I become a distributor or franchise partner for this product?

Interested distributors, stockists, and pharma franchise partners can contact Cafoli LifeCare Pvt Ltd to discuss monopoly territory rights, pricing structure, marketing support, and complete CNS product portfolio access to build a strong presence in the mental health and neuropsychiatry market.